Frontier IP Group (LON:FIPP) 65p £32.9m
Frontier IP, a specialist in commercialising intellectual property, has raised its equity stake in portfolio company Celerum Limited from 10 per cent to 33.8 per cent.
Dish of the day
Unconditional Dealings commence in Calisen () main mkt premium., raising £300m. Mkt cap £1.32bn.
Off the menu
No Leavers Today
What’s cooking in the IPO kitchen?
Intention to float by Gemfields Group. No Capital Raise. Currently listed on JSE. (JMB:GML) at circa £122m. The Group’s key producing assets, the Kagem emerald mine in Zambia (believed to be the world’s single largest producing emerald mine) and the Montepuez ruby mine in Mozambique (one of the most significant recently discovered ruby deposits in the world), are both expected to have long mine-lives with potential for expansion. Also owns the Faberge brand. Due Valentines Day 2020.
Main Market (Standard List)
The has announced its intention to list on the Standard Market. The Blockchain based business, owns patents to a protocol which facilitates dispute resolution based upon smart contract disputes. Transaction details TBC.
Main Market (Premium)
DRI Healthcare—investment company focused on investments in healthcare Royalty Assets looking to raise $350m. Due 11 Mar.
Ninety One –proposed demerger and public listing of Investec’s global asset management business on LSE and JSE. 30 Sep 2019 AUM £121bn. Sale of existing shares. Expected free float of 60%. Due 16 march.
Cabot Square—Closed ended investment fund focussed on alternative assets and asset manager. Looking to raise £200m. Will target investment opportunities that are expected to generate an attractive risk adjusted return and that can also make a positive ESG impact by focusing on some of the biggest challenges facing societies and economies. Due 14 Feb.
The Global Sustainable Farmland Income Trust will invest in a diversified portfolio of operational farmland assets located in major agricultural markets including the United States, Europe, New Zealand, Australia and certain countries within Latin and South America. Raising up to $300m. Due 28 February.
Investment firm is seeking to raise up to £200m at an issue price of 100p per share via an IPO. The company aims to invest in a portfolio of quoted Japanese stocks with market capitalisations of up to $1bn. First day of dealings expected early February.
Holdings () 31.5p £19.9m
The leading global immunodiagnostics group, today announces its half year results for the six months ended 30 November 2019.
Biodesix to launch EarlyCDT Lung in US by early March 2020
Service contract signed with a large pharmaceutical group
In late stage talks on multiple potential service contracts.
Revenue for the period was £0.31m. Cash £7.5m
Total administrative expenses were £5.11m (H1 2018: £2.63m); of which c.£1.3m relates to…